“Activating KCNJ11 Mutations in Neonatal Diabetes and Associated Neurodevelopmental Outcomes”

Learning Objectives:

1.            Understand the mechanism of KCNJ11 mutations.

2.            Discuss the association of neonatal diabetes and neurodevelopmental outcomes

3.            Discuss the role of sulfonylureas and their temporal effect on neurocognitive outcomes in KCNJ11 neonatal diabetes.

Presented by:  Michelle Lemelman, M.D.

Pediatric Endocrine Fellow, The University of Chicago


“Selenoprotein Cellular Defense in Arsenic-Induced Diabetes”

Learning Objectives:

1.            Review the impact environmental exposures on metabolic disease.

2.            Understand the relationship between arsenic exposure and diabetes.

3.            Review the potential role for selenoprotein-mediated cellular defense in arsenic-associated diabetes.

Presented by:  Mizuho Mimoto, M.D., Ph.D.

Endocrine Fellow, The University of Chicago


“Glycemic Profiles in Response to Short Term Dietary Modifications in Young Adults with GCK-MODY”

Learning Objectives:

1.            Update the audience on the status of my previous research study in neonatal diabetes.

2.            Discuss the basis for the current study, including as-yet unpublished data from quality-of-life surveys.

3.            Discuss the potential outcomes of the current study.

Presented by:  Susan Tucker, M.D.

Pediatric Endocrine Fellow, The University of Chicago


Session date: 
05/08/2017 - 5:00pm to 6:00pm CDT
UCMC M-170
Chicago, IL 60637
United States
  • 1.00 AMA PRA Category 1 Credit™
  • 1.00 Participation

Please login or create an account to proceed.
Speaker Name: 
Michelle Lemelman, MD; Mizuho Mimoto, MD, PhD; Susan Tucker, MD